Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 05, 2021

SELL
$84.42 - $106.62 $1,435 - $1,812
-17 Closed
0 $0
Q2 2020

Jul 28, 2020

SELL
$58.54 - $67.94 $2,517 - $2,921
-43 Reduced 71.67%
17 $1,000
Q4 2019

Jan 22, 2020

BUY
$49.86 - $58.26 $2,991 - $3,495
60 New
60 $3,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Savior LLC Portfolio

Follow Savior LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savior LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savior LLC with notifications on news.